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In the first paper of this series (1) a basis was constructed for deter- 
mining  the  minimal  amount  of  untreated  active  virus  of  equine 
encephalomyelitis  needed for the successful production of resistance in 
guinea pigs to 10  3  or 10' intracerebral lethal doses of the virus.  In the 
second article (2) we showed that formolized material induced, within 
certain limits, as high a degree of resistance as did untreated active 
virus, and this refractory state was shown not to be due to the action of 
"living" virus as such in the formolized immunizing preparation. 
The results of a study on humoral antibodies in guinea pigs treated 
with known quantities of active virus  and of virus inactivated by 
formalin (2) will be described in the present communication.  It was 
necessary first  to  determine the  optimal  conditions by  which the 
presence of serum antiviral  bodies  could be  brought to  light;  and 
having found the best  means for their demonstration, to  note any 
difference in content of antibody occurring in the serum of animals 
immunized with active and with inactive virus.  The findings served 
to explain certain phases of the mechanism of the resistance developed 
by guinea pigs after injections of formolized inactive virus. 
In early work on equine encephalomyelitis virus, Meyer, Hating, and Howitt 
(3)  reported  that  sera  of spontaneously recovered or resistant  horses  failed  to 
neutralize homologous virus,  while  those of recovered rabbits,  guinea pigs, and 
monkeys neutralized  only irregularly.  It was later shown that antiviral  bodies 
were demonstrable  in convalescent animals only when serum was added to low 
multiples of M.L.D. of virus (4, 5, 6).  Howitt (4, 7) recorded more constant pres- 
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ence of serum antibodies in recovered animals, especially horses, after hyperim- 
munization by means of reinjection with active virus.  In guinea pigs, moreover, 
tissue immunity conferred by vaccination was found to last longer than humorah 
resistance to  an  intracerebral test was  therefore present  without  demonstrable 
neutralizing bodies in the blood, but the converse could not be proved.  Hurst 
(8) found antiviral substance in the blood of surviving monkeys as early as the 4th 
day after peripheral inoculation of virus.  Neutralization of  1  to  10  M.LD. of 
virus as determined by the mouse intracerebral test could "almost invariably" be 
effected--in some instances even 100 to 1,000 x~.i.,.  Monkeys that withstood a 
later intracerebral or intramuscular injection of large amounts of virus did not 
reveal an appreciable increase of the neutralizing titer of their sera. 
Viewing  the  recorded  experiments  on  the  production  of  serum 
antiviral bodies in animals recovered from infection or immunized by 
virus inoculations, one observes that  the  antibodies occur irregularly 
or in low concentration. 
Materials and Methods 
Virus.--The  Eastern  strain of equine encephalomyelitis virus was employed 
as fresh or glycerolated guinea pig or mouse brain tissue.  Its activity was meas- 
ured by the results of intracerebral injection of mice (1). 
Animal Inoculation.--Guinea  pigs were immunized with active or formolized 
virus, as already described (I, 2).  In most instances mouse brain passage virus 
was used as immunizing preparation and in aU cases wherein guinea pigs were 
tested for induced immunity, the homologous passage virus was injected intra- 
cerebrally.  I 
Serum.--Pooled immune serum was employed, being derived from groups of 
animals, all of which were treated alike with either active or inactive virus.  Sera 
were collected, as a rule, from 4 to 8 days before tests were made.  Hyperimmune 
guinea pig serum was obtained from animals surviving intracerebral inoculation 
of virus and which, in addition, had resisted three later subcutaneous injections 
of 3  ×  108 to 6 ×  10 s mouse intracerebral infective units (m.i.u.) of virus (I, 2), 
given at weekly intervals.  These animals were bled for collection of serum 8 to 
I0 days after the last subcutaneous dose. 
Neutralization  Tests.--A preliminary test was always made to  determine the 
infectivity of a  stock virus suspension which consisted of infective mouse  brain 
ground in hormone broth pH 7.4 and spun in an angle centrifuge at 3,000  R.P.~¢. 
for 20 minutes.  This suspension, when  stored at S°C., was found to retain its 
original infectivity for at least 14 days.  In conducting the neutralization test, 
a Operative procedures on animals were performed with the aid of ether an- 
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TABLE  I 
Comparison  of the Antiviral  Content of Sera  of Guinea  Pigs  Treated with Active 
and with Formolized Virus.  Serum-Virus Mixtures Held at gO 
to 22°C. for 15 Minutes before Injection 
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Mice survivors  after  intra- 
cerebral  injection  of  serum- 
virus  mixtures 
Virus  dilutions  (absolute) 
In this and the succeeding table the numerator indicates the number of animals 
surviving; the denominator, the number of animals injected. 
A V  =  active virus; F V  =  formolized vaccine, the number following repre- 
senting  the  particular  vaccine  used;  i c  =  intracerebral;  s c  -  subcutaneous; 
N  T  =  not titrated for virus content prior to formolization. 
* Titration prior to formolization revealed 3  ×  107 m.i.u, per cc. 220  ~IZATION  WITH  ENCEPHALOMYELITIS  VIRUS.  III 
the stock virus was diluted decimally  in broth to 1:500,000,000 and to each dilution 
was added an equal volume of undiluted serum.  The resulting serum-virus mix- 
tures were tested soon after mixing (kept up to 20 minutes at room temperature) 
or after retention for 2 or 3 hours at 37°C.  Each of three mice was injected intra- 
cerebrally with 0.03 cc. of a serum-virus preparation. 
EXPERIMENTAL 
In Table I  is shown a  comparison of the antiviral body content of 
the sera of guinea pigs treated with active virus and with formolized 
vaccine.  The different serum-virus mixtures were tested at the same 
TABLE  II 
Comparative Effect  of Incubation  in  Revealing. Antiviral  Bodies  in  Serum-Virus 
Mixtures 
Sere 
Normal guinea pig 
Guinea pigs injected twice at 7 
days' interval with F V  XV. 
Bled 19 days later 
Guinea pigs injected once with 
3  X  10  B  m.i.u. A V.  Bled 30 
days later 
Hyperimmune guinea pig 
Serum-vlrUs  mixtures  injected 
up to 20 minutes after mixing  after 2~[ hours at 37"C. 
Virus dilutions  Virus dilutions 
10-~  10-4  10-5  10  -~ 10-~ 104  I0"9  10-a 10-410-5 10-t 10-710-s 104 
0/3o/3o/3o/3  0/3 1/33/3 
0/3 0/3 0/3 0/3 2/3 3/3 3/3 
0/3 o/3 0/3 3/3 3/3 3/3 3/3 
0/3 0/3 1/3 2/3 3/33/3 3/3 
O/3 0/3 O/3O/3O/3 0/3 3/3 
O/3 0/3 O/3 2/33/3 3/3 3/3 
0/3 013 013 2/33/3 3/3 313 
3/3 2/33/33/3'3/3 3/33/3 
Abbreviations as in Table ~[. 
time and in each case were held at room temperature not longer than 
20  minutes  before  being  injected  intracerebrally  in  mice.  It  is 
apparent that under these conditions only the hyperimmune guinea 
pig serum revealed an appreciable quantity of virus antibodies, i.e.~ 
neutralizing 100  to  1,000  M.I.D.  The sera derived from guinea pigs 
which resisted the intracerebral test for induced immunity exhibited 
partial or  complete protection against only 1  to  10  M.I.D. of virus. 
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bring  about  immunity against  the  intracerebral test  for resistance 
possessed  no significant humoral protective properties.  Finally, no 
distinct difference  could be seen in antibody content of serum collected 
from guinea pigs treated with active or inactive virus. 
Table II summarizes the experiments on the relation of incubation 
to titration of humoral antiviral bodies.  Incubation clearly enhanced 
the protective substance in equine encephalomyelitis  antisera.  Here a 
tenfold increase was demonstrable in all of the immune sera tested. 
Hence to reveal small amounts of antiviral bodies it is best to incubate 
serum-virus mixtures before animal inoculation. 
SUMMARY  AND  DISCUSSION 
An analysis of the preceding experiments discloses  that antiviral 
bodies are demonstrable not at all or in small amounts in the sera of 
guinea pigs injected with a  quantity of active virus not sufficient  to 
induce immunity against the described intracerebral test for induced 
resistance.  However,  neutralizing  bodies  are  found  in  immune 
animals, although in low concentration, and are regularly manifested 
when serum is added to low multiples of infective doses of virus under 
optimal conditions of time and temperature.  Hyperimmune serum, 
on the other hand, reveals a distinct increase in the amount of antiviral 
bodies present. 
Irrespective of the  mode of procedure for revealing neutralizing 
bodies, there does not appear to be any notable difference in the con- 
tent of such bodies in the serum of animals immunized with active 
virus or with formolized vaccine in which active virus could not be 
demonstrated.  In other words, the antigenic complexes in active as 
well as in inactive virus produce similar degrees of antibody reaction. 
The formolization of virus tissue suspensions,  therefore, can be con- 
sidered as a process whereby the virus is inactivated but the antigen- 
icity of the suspensions  is preserved, as is also shown in the preceding 
paper of this series  in  tests on tissue immunity.  In that article is 
described  the  remarkably high  degree  of  tissue  immunity  which 
results from injections of inactive virus; now we demonstrate that this 
resistance is associated with a minimal degree of serum antibody. 
Finally, the question may well be asked, if practically no antiviral 
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serum  and  virus,  and  are  recognizable in  a  tenfold increase when 
functions of time and temperature are brought into play, whether the 
bodies are "neutralizing" or the phenomenon is due merely to aggrega- 
tion of virus particles by the serum.  From the recent work on the 
same virus and immune serum  (9)  by Merrill,  there appears  to  be 
warrant for the belief in aggregation of virus particles which in turn 
diminishes the virus activity to the indicated degree. 
CONCLUSIONS 
Guinea  pigs  injected  with  amounts  of  active  equine  encephalo- 
myelitis virus inadequate to induce protection against an intracerebral 
test  of  1,000  or  more  M.L.D. of virus  show  no  significant humoral 
anfiviral bodies.  The latter  are,  however, regularly present in im- 
mune animals and are  best  demonstrated  by adding serum to low 
multiples of infective doses of virus under optimal conditions of time 
and temperature (2½ hours at 37°C.).  Guinea pigs immunized either 
with active or with inactive  (formolized) virus reveal no distinctive 
differences in the antiviral body content of their sera. 
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